Trade Mark Journal No.2026/016 17 April 2026
UK00004346607 27 February 2026 (9,42)
BioOptimus
International priority date claimed: 25 February 2026
(European Union Intellectual Property Office (EUIPO))
(019321877)
- Class 9
- Downloadable computer software platforms for collecting, processing and analysing biological and scientific data for research; downloadable software for computational modelling and simulation of biological systems using multimodal data; downloadable computer software using artificial intelligence (AI) for data processing, data generation and data analysis; downloadable computer software using artificial intelligence (AI) for developing learning algorithms for data classification and decision support; downloadable software for simulation environments to test AI algorithms; downloadable computer software using artificial intelligence (AI) for conducting research in biology and life sciences; downloadable computer software using artificial intelligence (AI) for biological model development and for analysis and prediction in oncology, chemistry, biology, cosmetics, agroengineering, agrochemistry, longevity medicine and personalised medicine; downloadable software for deep learning, reinforcement learning, building neural networks, high performance computing, distributed computing, cloud computing, data analytics, mechanistic machine learning; downloadable application programming interface (API) for scientific modelling; downloadable software development kits (SDK); downloadable software for scientific modelling; downloadable software for scientific modelling, namely, artificial intelligence (AI) model weights; downloadable software using machine learning for tumour profiling and diagnostic modelling ; all the aforementioned goods being provided exclusively in digital, or computational form and excluding any goods involving the manipulation of living organisms, biological materials or samples, or any in vivo or in vitro genetic engineering process.
- Class 42
- : Providing on-line non-downloadable software for collecting, processing, integrating and analysing biological and scientific data for research; research in the field of artificial intelligence (AI) technology; consultancy in the field of artificial intelligence; computer technology consultancy in the field of machine learning; technological consultation in the field of data analytics; research and development services in the field of engineering; providing on-line non-downloadable software for computational modelling and simulation of biological systems using multimodal data; providing on-line non-downloadable software for conducting research and tests in biology and life sciences using artificial intelligence (AI); biotechnology research; research and development services in the field of diagnostic preparations; computer programming consultancy; providing on-line non-downloadable software for biological model development and for data analysis and prediction in oncology, chemistry, biology, cosmetics, agroengineering, agrochemistry, longevity medicine and personalised medicine, using artificial intelligence (AI); providing on-line non-downloadable software for deep learning, reinforcement learning, building neural networks, high performance computing, distributed computing, cloud computing, data analytics, mechanistic machine learning; providing on-line non-downloadable software for modelling organic compounds and tumour profiling; providing on-line non-downloadable software for creation of machine learning diagnostic models; providing on-line non-downloadable software for analysis of genomic, proteomic and histology, pharmacokinetic, pharmacodynamics, clinical outcomes; medical and scientific research, namely, conducting clinical trials for others; providing on-line non-downloadable software for scientific modelling, namely, software development kits (SDK) and application programming interface (API); all the aforementioned services being provided exclusively in digital or computational form and excluding any services involving the manipulation of living organisms, biological materials or samples or any in vivo or in vitro genetic engineering process.
BIOPTIMUS
Representative: Page, White & Farrer Limited